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                                                                               Introduction 
 
 
 
Glucose transporter type I deficiency syndrome (GLUT-1 DS) is a 
metabolic encephalopathy, caused by a defect of glucose uptake,  
mediated by GLUT-1, at the blood-brain barrier and into brain cells. 
[1;2] 
GLUT-1 is a membrane-bound glycoprotein that provides base rate 
glucose transport across blood-tissue barriers. [3] 
The gene exclusively associated with GLUT-1 is SLC2A1, located on 
chromosome 1 (1p34.2).[4]      It is a relatively small gene and 
consists of ten exons, spanning 2842 base pairs encoding 493 
aminoacids. [4; 5] 
The structure and function of the GLUT-1 protein has been intensively 
investigated. [4; 5] It has been identified and described for the first 
time in 1985 by Mueckler. (Figure 1) [2; 5]    
The amino-acid sequence of the GLUT-1 protein is highly conserved, 
with 97-98% identity between the human, rat, rabbit, mouse and pig 
sequences, which implies that all domains of this protein are 
functionally important. [6]  
Its structural model contains 12 transmembrane domains, spanning the 
plasma membrane as alpha-helices with intracellular located amino-
and-carboxyl-termini. Helices 6 and 7 are separated by a large 
intercellular loop. The postulated three-dimensional structure is 
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characterized by a central channel across the protein, connecting the 
extracellular and intracellular environments. Crucial domains for 
transport and pathogenicity are clustered around the central channel 
and in the long intracellular loop. (Figure 1) [2; 5; 7]  
GLUT-1 is constitutively expressed in erythrocytes, brain 
microvessels and astroglia. 
In brain, GLUT-1 has been detected in two different isoforms encoded 
by the same gene and differing only in their extent of glycosylation: 
the 55 Kda isoform, located in the endothelial cells of brain 
microvessels and erythrocytes and  the 45 Kda isoform,  detected in 
most cells including astrocytes and maybe responsible for basal 
glucose uptake into these tissues. [8] 
Most of  SLC2A1 mutations detected occurred de novo as a sporadic 
autosomal dominant condition, resulting in GLUT-1 
haploinsufficiency. [9; 10] 
Recently, however, an autosomal dominant mode of transmission was 
indentified in several unrelated families. [11; 12]            
Finally,  Klepper et al.,  for the first time, have shown that GLUT-1 
DS can be also transmitted as an autosomal recessive disease. [13] 
All mutations are heterozygous and mostly private; infact, 
homozygous GLUT-1 mutations presumably are lethal in utero, this 
observation is confirmed in GLUT-1 knockout mice. [14] 
      
To date,  about 100 different mutations in the SLC2A1 gene has been 
described in approximately 200 patients, including large-scale 
deletions, missense, nonsense, frame shift and splice-site mutations.  
(Figure 2) [15]  
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All mutations either lead to absence or loss of function of one of the 
SLC2A1 alleles.  
Generally, patients with missense mutations often present  moderate to 
mild symptoms,  but we noted that the expressivity is variable and the 
penetrance can be incomplete and so we underline that genotype-
phenotype correlation in GLUT-1 DS is complex and it is not yet 
clearly defined. [16; 17] 
 
 
Classic clinical phenotype associated to GLUT-1 deficiency was first 
described  by De Vivo et al. in 1991 and it includes a range of 
complex movement disorders (as ataxia, dystonia, paroxysmal 
induced dyskinesia,  spasticity),  epilepsy,  often drug resistant,  
mental retardation,  acquired microcephaly,  with onset under a year 
of age.  [18] 
In recent years, many atypical variants associated with different 
mutations of SLC2A1 gene have been described.  In these atypical 
phenotypes seizures,  movement disorders and  mental delay can 
occur either separately or in different combinations.    Particularly, a 
group of patients can present prominent movement disorders without 
seizures or exclusively paroxysmal exercise-induced dyskinesia 
(PED), or exclusively epilepsy, for example early onset absence 
epilepsy (EOAE) or classic generalized epilepsy (IGE) or childhood 
absence epilepsy (CAE). (Figure 3) [16; 19; 20; 21; 22] 
About epilepsy, no specific seizure type has been identified because 
GLUT-1 DS is associated with a wide range of epilepsies.  
Generally, patients develop seizures in infancy and early childhood, 
that  frequently do not respond to anticonvulsivant drugs.  
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In infants, seizures are described as brief, subtle myoclonic limb 
jerking with staring alternating with eye-rolling, a sudden onset of 
pallor, a dazed expression or horizontal roving eye movements, 
unresponsiveness, and hypotonic as well as head bobbing. [16; 27]       
Later in childhood, seizures often appear to be myoclonic and 
generalized. Surprisingly, familial GLUT-1 deficiency has recently 
been associated with IGE, especially EOAE. [20; 23; 24; 25] 
IGE syndromes associated with GLUT-1 DS are usually, but not 
always, drug responsive and individual cases may be phenotypically 
indistinguishable from common forms of IGE. In particular, a recent 
family study has shown that of  15 subjects with SLC2A1 mutation, 
epilepsy occurred  in 12; epilepsy phenotypes varied widely, including 
IGE with absence, myoclonic-astatic epilepsy and focal epilepsy; 
furthermore, PED occurred in just under half of the family members 
and 1 individual PED was present without seizures. So, we think that 
GLUT-1 deficiency should be suspected where the family history 
suggest a dominant inheritance of  IGE or  PED, expecially where 
PED and IGE coexist in the same  family. [20; 23; 25]  
Previously, the same authors found that GLUT-1 DS accounts for over 
10% of EOAE, beginning before 4 years of age; these patients 
presented milder phenotypes of  GLUT-1 deficiency because they had 
normal development before seizures onset, good AED seizures 
control, and intellectual outcome range from normal to moderately 
impaired.  Thus,  in these patients,  the seizure phenotype could not be 
readily distinguished from CAE, except for the earlier age of onset.  
Probably, GLUT-1 DS may underline a significant proportion of 
EOAE, in particular those with atypical features. [26; 27]  
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Furthermore, it is very important to remember that same patients show 
prominent movement disorders other than epilepsy. Then, epilepsy 
and movement disorders can occur either separately or in 
combination. [16; 19; 28; 29] 
 
 
Purpose of this study is to research mutations in SLC2A1 gene in a 
population of patients with early onset epilepsy with or without mental 
delay and movement disorders; to analyze phenotype-genotype 
correlations and to study first-degree relatives to evaluate the possible 
reduced penetrance. 
 
 
 
 
 
Figure 1: Conformational model of GLUT-1 in the cellular membrane.  
                 The GLUT-1 protein shows 12 transmembrane helices with a large  
                 intracellular loop connecting helix 6 and 7, the N-glycosylation site in the  
                 first extracellular loop, and the amino- and carboxy-termini located in the  
                 cytosol. [2] 
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    Figure 2:    List of the main pathogenic mutations identified to date [15] 
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    Figure 3: Clinical phenotypes and severity of GLUT-1 disease.  
                     Seizures,  movement disorder and mental delay can occur  
                     either separately or in combination [22] 
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            Materials and methods 
 
 
 
 
 
In the first part we have selected a population of  98 patients  with: 
 
1. Early onset (within 4 years) epilepsy drug resistant and/or drug 
responsive; 
2.  Early onset (within 4 years) drug resistant and / or drug responsive 
associated with cognitive impairment and / or movement disorders. 
 
All selected patients underwent to neurological evaluation with 
physical examination and collection of medical history with data 
concerning pregnancy, child-birth, possible presence of acquired 
microcephaly and evaluation of psychomotor development.  
Data were collected on the age of onset of epilepsy, the frequency of 
seizures and their semeiological characteristics  and possible triggers 
of the seizures. 
Blood samples obtained from selected individuals were sent at the 
“Gaslini Institute” of Genoa to search for mutations in the SLC2A1 
gene, which was carried out by PCR for the detection of missense 
mutations and MLPA for the detection of possible deletions and/or 
translocations. 
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Furthermore, we have submitted all selected patients to neuroimaging 
examinations (brain MRI and brain PET).   
Each of the patients with mutations on SLC2A1 gene was followed 
serially in a quarterly checks.  During each follow-up visit the patient 
proceeded: 
- Neurological examination pre- and post-prandial; 
- Video-EEG long-term pre- and post-prandial; 
- EEG monitoring in long-term sleep; 
- Neuropsychological study with evaluation of the IQ by Wischler 
stairs: 
       • WISC-R for children between 6 and 16 years old; 
       • WAIS for patients with more than 16 years. 
- research and study of potential specific learning disabilities. 
 
In addition, the genetic study was extended to all family members. 
In the end, for each family member with a mutation of SLC2A1 gene 
was collected clinical history, was performed a neurological 
examination and a video-EEG recording long-term pre- and post-
prandial. 
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                                                                     Results 
 
 
 
 
Following the analysis of 98 selected patients 4 subjects were  
identified with 4 different mutations in the SLC2A1 gene.  
All 4 patients presented heterozygous missense mutations, never 
previously described, which determined an aminoacid substitution in 
an exon of the SLC2A1 gene. 
 
Below we will analyze in detail the individual cases with clinical 
insights performed on individual patients and their familia and with 
the results obtained. 
 
The first case that we want to describe is the case of  A.M., ♀ 49 yo., 
born at term by vaginal delivery, after a normal pregnancy.   
Her family history is negative for epilepsy and febrile seizures.  
She has presented a normal psycomotor development until the age of 
21 months, when  she has showed a cognitive delay and presented the 
first seizures, before infantile spasms and after, at the age of 36 
months, myoclonic seizures. About interictal/ictal EEG of that time 
the documentation in our possession is very poor. We have only a few 
old interictal EEG that, however, show generalized spikes, polispikes 
and polispikes-waves complex. (Figure 4)  
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Over the years, A.M. has taken many different therapies, often with 
the association of more drugs (for example: valproic acid, 
ethosuximide, clobazam and clonazepam).  
Actually A.M. have no seizures from the age of 40 years and her 
current therapy is a valproic acid (500 mg/die) and clobazam (10 
mg/die) association.    
Her neurological examination shows an awkward and slightly unstable 
gait, with lightly enlarged base and her neuropsychological study 
shows a moderate mental delay (WAIS-R: VIQ: 55; PIQ: 61; TIQ: 
53). 
We have performed serial fasting and after meal EEG, all with normal 
results. 
Furthermore we have submitted our patient to brain MRI and brain 
PET.  
There are not reported alterations in Brain MRI, instead Brain PET 
shows a reduction of tracer distribution in the cerebral cortex in 
relation to the striated, appearing preserved/hypermetabolic. The more 
evident reduction is in the temporal, particularly in  
mesial/hippocampal , regions  bilaterally,  in both thalamus, in 
brainstem and cerebellum (hemispheres and worm). (Figure 5) 
In the end, the analysis of the SLC2A1 gene shows a mutation c.844 
C> G in exon 6 in the heterozygous state, that determines a 
substitution of  Glutamine in position 282 with a Glutammic acid  
(p.Gln282Glu).   
This mutation is not present in the mother; instead we could not study 
the father who had died.  
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    Figure 4:   A.M., ♀ 49 yo., interictal EEG that shows generalized spikes, 
                       polispikes and polispikes-waves complex. 
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    Figure 5:   A.M., ♀ 49 yo., BRAIN PET that shows a reduction of tracer 
                      distribution in the temporal lobe, particularly in mesial/  
                      hippocampal regions  bilaterally,  in both thalamus, in 
                      brainstem and cerebellum (hemispheres and worm). 
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The second case we have identified is that of A.S., ♀, 15 yo. 
This patient was born at term by vaginal delivery, after a normal 
pregnancy. 
She has a cousin in paternal line that suffers of epilepsy.  
She has presented a normal psycomotor development until the age of  
15 months, when appeared episodes such benign paroxysmal vertigo 
and gradually revealed a cognitive delay associated with dysgraphia, 
dyslexia and dyscalculia. 
Later appeared atypical absences with myoclonic component and rare 
tonic-clonic generalized seizures (CTGS). 
We have recorded an atypical absence with a critical EEG that shows 
long sequences of  slow spikes/waves complex in bi-frontal areas  
(> left) of 2-2.5 Hz, with a tendence to a diffusion. (Figure 6) 
The intercritical EEG were characterized initially by generalized 
spikes/waves and spikes/waves complex in bi-frontal areas 
asynchronously; later, by slow spikes/waves complex in bi-frontal 
areas (> left) and rare spikes/waves complex in right parietal 
paramedian area. (Figure 7) 
 
By the age of 12 yo seizures are disappeared and after meal EEG are 
normal instead all fasting EEGs show small sporadic isolated wave-
sharp/slow-wave complex on the left frontal and temporal regions. 
(Figure 8)  
Actually A.S. takes a combination of 3 drugs: valproic acid (500 
mg/die); etosuximide (500 mg/die) and lamotrigine (75 mg/die). 
Her current neurological examination shows disharmonious gait with 
light ataxia and a moderate difficulty in fine movements.   
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The neuropsychological study evinces a light mental retardation 
(WISC-R: QIV: 78; QIP: 45; QIT: 59) associated with dysgraphia, 
dyslexia and dyscalculia. 
Our patient has performed a brain MRI resulted normal and a brain 
PET that shows a slight reduction of the distribution of the tracer in 
the frontal cortex and in the upper part of the thalamus, bilaterally. 
(Figure 9) 
Molecular genetic analysis of SLC2A1 gene showed a mutation c.667 
C>T in exon 5 in the heterozygous state, that determines a substitution 
of Arginine in position 223 with a Tryptophan (p.Arg223Trp).  
The same (new) mutation is present in her father (F.S., ♂, 55 yo), who 
never presented clinical seizures, but whose fasting EEG shows the 
presence of a widespread slowdown in hyperpnea and sporadic  
bifrontal wave-sharp/slow-wave complex. (Figure 11) 
Furthermore, we submitted this patient to a brain MRI resulted normal 
and to a brain PET that, instead, highlights some alterations: a 
reduction of the tracer in left parietal, temporal, occipital and 
cerebellar cortex. (Figure 10) 
In this family we have studied even the mother of our patient that has 
not mutations in the SLC2A1 gene and the cousin of the paternal line 
that  presents a form of epilepsy similar to that of our patient but drug 
responsive. In this child, the onset of seizures was at the age of 4 yo 
with seizures of  benign paroxysmal vertigo, as our patient. However 
he doesn’t show movement disorders and mental delay but he has 
presented only an acquisition delay of the language. Even for this 
patient we have researched mutations on SLC2A1 gene, but no 
mutations was found. 
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    Figure 6:   A.S., ♀, 15 yo. - an atypical absence with a critical EEG with a sequence of 
                      slow spikes/waves complex in bi-frontal areas (> left) of 2-2.5 Hz, with  
                      a tendence to generalization. 
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    Figure 7:   A.S., ♀, 15 yo. - intercritical EEG characterized by slow spikes/waves 
                      complex in bi-frontal areas (> left). 
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    Figure 8:   A.S., ♀, 15 yo. - actual fasting intercritical EEG characterized by small, sporadic 
                      and isolated wave-sharp/slow-wave complex on the left frontal and temporal  
                      regions. 
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    Figure 10:    F.S., ♂, 55 yo  - BRAIN PET characterized by a reduction of the tracer in left 
                          parietal, temporal, occipital and cerebellar cortex. 
    Figure 9:   A.S., ♀, 15 yo. - BRAIN PET characterized by a slight reduction of the 
                      distribution of the tracer in the frontal cortex and in the upper part of the thalamus, 
                      bilaterally. 
22 
 
                                                                                                                              
           GLUT-1 Deficiency Syndrome: phenotype-genotype correlations                             
 
 
 
 
 
    Figure 11:   F.S., ♂, 55 yo -  after meal EEG: normal; fasting EEG with sporadic 
                        bifrontal wave-sharp/slow-wave complex that are increased during 
                        hyperpnea. 
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The third case that we have identified is that of  V.E.B., ♂, 21 yo. 
He was born at term by vaginal delivery after a normal pregnancy. 
His family history of epilepsy and/or febrile seizures is negative. His 
psychomotor developmental is reported normal. He presented seizures 
from the age of about 8 months before as infantile spasms and later as 
absences seizures. By the age of 13 yo he is seizures free but he still 
takes levetiracetam to a low dosage (500 mg/die).  
Currently he presents episodes of paroxysmal dyskinesia fasting. 
His actual neuropsychological studies, his IQ and his brain MRI are 
normal. 
On the contrary his brain PET shows a reduction of the tracer 
bilaterally in the frontal cortex, thalamus and cerebellum than in 
striated hypermetabolic. 
Molecular genetic analysis of  SLC2A1 gene shows a mutation c.443 
C> T in the heterozygous state, that determines a substitution of 
Leucine in position 148 with a Serine (p.Leu148Ser). 
This mutation was researched in his parents but no mutations are 
identified. 
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In the end, the fourth case we have identified and studied is the case 
of  D. L.,  ♂, 13 yo. He was born at term by vaginal delivery after a 
normal pregnancy. 
He has a family history of epilepsy. His psychomotor developmental 
is reported normal. The onset of the seizures was at the age of three 
years with the appearance of typical absences with an EEG pattern of  
typical spikes/waves complex to 3 Hz. (Figure 13)   Currently he has 
no seizures  from the age of 12 yo and he takes lamotrigine to low 
dosage. His neuropsychological studies with IQ and brain MRI are 
normal. On the contrary, brain PET evinces a relative reduction of the 
tracer in the cerebellum (vermis and hemispheres) and, less markedly, 
in the thalamus bilaterally. (Figure 12) 
We have executed a molecular genetic analysis of SLC2A1 gene that 
showed a mutation c.694 C> T in the heterozygous state, that causes a 
substitution of Arginine at position 232 with a Cysteine 
(p.Arg232Cys). 
We have studied all members of this family and we have identified the 
same mutation in all 8 living affected individuals and in 4 adult 
healthy carriers (II-4, II-5, III-3 and III-4). (Figure 14)      The family 
comprises 9 individuals (8 living) across 3 generation affected by IGE 
with variable phenotypes.  None of the affected individuals had other 
neurologic manifestations, including movement disorders.  All 
subjects had generalized seizures, mainly typical absences, with 
variable age at onset (early childhood to 23 years).  During childhood, 
patients  II-7, III-5, III-7 and III-8 had daily, frequent (up to hundreds 
each day) episodes of sudden, brief impairment of consciousness and 
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interruption of the ongoing activity. Patient III-8 had also occasional 
tonic-clonic seizures. In these patients, ictal EEGs showed regular and 
symmetric generalized discharges of 3-3.5 Hz spike wave complexes 
on normal background activity, as typically observed in childhood 
absence epilepsy. (Figure 15)  Seizures remitted within 2-5 years 
from onset. However, patient II-7 started experiencing myoclonic 
jerks after awakening and generalized tonic-clonic seizures 
precipitated by sleep deprivation in his midteens, as seen in juvenile 
myoclonic epilepsy. His EEGs showed regular and symmetric 
generalized discharges of 3-3.5 Hz spike wave complex and polispike 
wave complex on normal background activity. Patients III-1 and III-2 
experienced weekly, long-lasting (up to 10 minutes) absences starting 
around age of 10 years. Their EEGs showed generalized discharges of 
3.5-4 Hz spike wave complexes on normal background activity.  
Patient II-2 was “ asymptomatic” at the age of 23 years but a video-
EEG revealed typical 3-3.5 Hz spike wave discharges accompanied by 
subtle impairment of consciousness during hyperventilation (phantom 
absences in adult-onset absence epilepsy). She accepted treatment 
only after a generalized tonic-clonic seizure. (Figure 16 and 17) 
Patient III-11 has presented absence seizures starting from 3 years of 
life. His EEGs showed frequent, spontaneous bursts of generalized 
irregular spike-wave discharges, occasionally accompanied by atonic 
components and head drop. Although all affected member of the 
family had normal neurologic examination and showed excellent 
response to pharmacologic therapy, individual III-11 showed 
borderline intellect and was drug resistant, despite add-on of 
ethosuximide and levetiracetam. A ketogenic diet was not tolerated 
because of severe diarrhea and nausea.  
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EEGs were normal in 7 healty subjects (II-4, II-5, III-3, III-4, III-9 and 
III-10). 
All these patient have done a brain MRI resulted normal but, 
unfortunately, at the moment, all these family members of our patient 
have refused to make a brain PET. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Figure 12:   D. L., ♂, 13 yo - Brain PET evinces a relative reduction of the tracer in the  
                         cerebellum (vermis and hemispheres) and, less markedly, in the thalamus 
                         bilaterally. 
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    Figure 13:   D. L., ♂, 13 yo - a typical short absence with a critical EEG         
      pattern of typical spikes/waves complex to 3 Hz. 
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    Figure 14:   D. L., ♂, 13 yo - genealogical tree with all members of family: 8 living 
                       affected individuals and in 4 adult healthy carriers (II-4, II-5, III-3, III-4).  
                      Table with the clinical features of the members with mutations: the family  
                      comprises 9 individuals (8 living) across 3 generation affected by IGE with  
                      variable phenotypes.   
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    Figure 15:   Pt. III-8 D. L., ♂, 13 yo - ictal EEG with regular and symmetric 
                        generalized discharges of 3-3.5 Hz spike wave complexes on normal 
                        background activity, as typically observed in childhood absence epilepsy. 
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    Figure 16:   Pt. II-2  -  EEG that reveals typical 3-3.5 Hz spike wave discharges  
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    Figure 17:   Pt. II-2  - another intercritical EEG with typical 3-3.5 Hz spike wave 
                        discharges. 
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                                           Discussion and Conclusions 
 
 
 
 
GLUT-1 deficiency syndrome is a metabolic encephalopathy whose 
classical phenotype, described for the first time by De Vivo in 1991, 
includes a clinical picture of extreme gravity characterized by: early 
onset epilepsy, usually drug-resistant, mental delay, acquired 
microcephaly and a large group of movement disorders (ataxia, 
choreoathetosis, dystonia, paroxysmal exercise-induced dyskinesia, 
spasticity). [2; 18] Over the years, about 200 cases have been 
described, many of which constitute atypical variants where seizures, 
movement disorders and mental delay can occur either separately or in 
different combinations. [15; 16]  
To date, genotype-phenotype correlations are poor. Leen et al., in 
2010,  have attempted to delineate a possible correlation 
phenotype/genotype for this syndrome.  They say that severe 
mutations resulting in complete loss of one allele are typically 
associated with the classic GLUT1-DS phenotype, whereas 
heterozygous missense mutations with a residual function are more 
often found in milder phenotypes. [15] 
In our study, we have identified in 16 different subjects 4 different 
missense mutations never described in literature and associated with 
atypical phenotypes, often not so “mild”. 
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Particularly, we have found a missense mutation in a patient with a 
rather severe phenotype, with an association of moderate mental 
delay, epilepsy and slight movement disorder.  
Moreover we have identified another missense mutation, never 
described in literature,  in a patient with a phenotype not so mild, that 
presented epilepsy associated with movement disorder and a light 
mental delay, and in her father, that, instead, presented a very mild 
phenotype with only instrumental but apparently not clinical signs.  
Also we have found a patient with an IGE and a missense mutation in 
SLC2A1 gene, and we have found the same mutation in 11 his family 
members including 4 healthy subjects. 
In light of everything, we have noted a big clinical variability, even 
evident in neuroimaging (brain PET), where both patients with the 
same mutation that patients with different mutations presented a 
different panel of brain PET, often not correlated with the patient's 
clinical panel, as shown in the recent literature by Akman in 2015. 
[30; 31] 
  
Unlike what reported in the literature, these observations demonstrate 
that mild mutations (missense mutations) are found both in severe 
phenotypes that in milder phenotypes. So, we can say that these 
results highlight the fact that other modifying genetic and/or acquired 
environmental factors may influence the underlying pathophysiology 
and clinical expressivity. Novel genetic methods may be able to detect 
the underlying reason for this phenomenon. 
 
Another important aspect is the treatment of this syndrome. In the 
literature the treatment of choice for GLUT-1 DS is a ketogenic diet 
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(KD). It is a high-fat, carbohydrate-restricted diet that mimics the 
metabolic state of fasting; so, the KD relies an exogenous rather than 
body fat for ketone production, thus maintaining ketosis without 
weight loss. [32]  In GLUT-1 DS the ketone bodies generated from 
dietary fatty acid oxidation in the liver readily penetrate the blood-
brain barrier and provide an alternative fuel for brain metabolism.  
As developing brain requires substantially more energy in young 
children, the ketogenic diet should be started as early possible 
whenever GLUT-1 DS is suspected and should be continued at least 
until adolescence. [33] 
To date, in literature,  it seems that, particularly epilepsy, but also 
movement disorder are positively affected by ketogenic diet, while, 
the impact of  KD on developmental delay appears less prominent. 
[15; 28] Recently, also the modified Atkins Diet has been used 
successfully in patients with GLUT-1 DS and it may offers  a good 
alternative in schoolchildren and adolescents, with difficulties 
maintaining a classical KD. [34] 
We must underline that some pharmacological agents impair GLUT-1 
function and should be avoided; these substances include: ethanol, 
methylxanthines, caffeine, androgens, dioxine, tricyclic antidepressant 
and anticonvulsivants such as Phenobarbital, diazepam and valproic 
acid. [35] 
 
The patients in our study taking antiepileptic drugs, especially 
valproic acid, with often the disappearance of seizures. None of the 
patients tolerated the ketogenic diet and the attempt to replace the 
drug did not bring changes in the patient, but only, in some patients, 
the recovery of seizures. For this reason it was decided to leave 
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unchanged the therapy, also because the majority of our patients with 
GLUT-1 DS  are  adults, in which the diagnosis has come too late. 
 
So, we underline that the early identification of children with GLUT-1 
DS is important to prevent treatment with anticonvulsivants that may 
be ineffective or potential detrimental, and to initiate an alternative 
energy source during a time of increased cerebral metabolism. 
 
In conclusion, we emphasize that the identification and the description 
of new patients and families affected by syndrome of deficiency of 
GLUT-1 and the characterization of the phenotype, as well as the 
exact correlation with the genotype is essential to better delineate this 
syndrome and its clinical spectrum, for genetic counseling, for the 
possible therapeutic implications and for prognostic information. 
  
In the future,  we hope that studies are carried out aiming the 
identification and functional characterization of novel mutations in the 
SLC2A1 gene in order to contribute to better knowledge about the 
functions of this gene in the epileptogenesis and more generally on the 
pathophysiological mechanisms underlying this syndrome and its 
symptoms. 
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